CANCER CAPITAL CORP.: 10-Q filed 2022-08-12

Name: CANCER CAPITAL CORP.: 10-Q filed 2022-08-12
Creator: CANCER CAPITAL CORP.

What CANCER CAPITAL CORP. reported in its quarterly report filed 2022-08-12 (fiscal Q2 2022): 18 published measures, 55 facts as tagged in accession 0001554795-22-000287.

This filing

Form: 10-Q (quarterly report)
Filed: 2022-08-12
Fiscal period: fiscal Q2 2022
Accession: 0001554795-22-000287 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CANCER CAPITAL CORP. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2022-06-30	20,453	USD
At 2021-12-31	62	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2022-06-30	412,041	USD
At 2021-12-31	369,194	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2022-06-30	-391,588	USD
At 2022-03-31	-383,330	USD
At 2021-12-31	-369,132	USD
At 2021-06-30	-350,606	USD
At 2021-03-31	-342,234	USD
At 2020-12-31	-332,340	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2022-06-30	20,453	USD
At 2021-12-31	62	USD
At 2021-06-30	1,198	USD
At 2020-12-31	698	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	-8,258	USD	91
2022-01-01 to 2022-06-30	-22,456	USD	181
2022-01-01 to 2022-03-31	-14,198	USD	90
2021-04-01 to 2021-06-30	-8,372	USD	91
2021-01-01 to 2021-06-30	-18,266	USD	181
2021-01-01 to 2021-03-31	-9,894	USD	90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2022-01-01 to 2022-06-30	-7,609	USD	181
2021-01-01 to 2021-06-30	-3,200	USD	181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2022-01-01 to 2022-06-30	28,000	USD	181
2021-01-01 to 2021-06-30	3,700	USD	181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2022-06-30	-444,788	USD
At 2021-12-31	-422,332	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	-2,850	USD	91
2022-01-01 to 2022-06-30	-11,960	USD	181
2021-04-01 to 2021-06-30	-3,800	USD	91
2021-01-01 to 2021-06-30	-9,200	USD	181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2022-06-30	20,453	USD
At 2021-12-31	62	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	2,505	USD	91
2022-01-01 to 2022-06-30	4,691	USD	181
2021-04-01 to 2021-06-30	1,789	USD	91
2021-01-01 to 2021-06-30	3,500	USD	181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2022-06-30	412,041	USD
At 2021-12-31	369,194	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2022-06-30	1,350	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	2,850	USD	91
2022-01-01 to 2022-06-30	11,960	USD	181
2021-04-01 to 2021-06-30	3,800	USD	91
2021-01-01 to 2021-06-30	9,200	USD	181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2022-06-30	6,150,000	shares
At 2021-12-31	6,150,000	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2022-06-30	47,050	USD
At 2021-12-31	47,050	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	2,850	USD	91
2022-01-01 to 2022-06-30	11,960	USD	181
2021-04-01 to 2021-06-30	3,800	USD	91
2021-01-01 to 2021-06-30	9,200	USD	181

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	-5,408	USD	91
2022-01-01 to 2022-06-30	-10,496	USD	181
2021-04-01 to 2021-06-30	-4,572	USD	91
2021-01-01 to 2021-06-30	-9,066	USD	181

Inspect the source

Entity: CANCER CAPITAL CORP. / CIK 0001130889
Captured: 2026-09-21T17:18:27.452Z
SEC response SHA-256: d5d1b1f4978812654637bca868297ef525c382823f5e2c59b0d5ad6b7a1cebf9

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001130889.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))